ASX:MSB

Email Alerts for:
ASX:MSB

Mesoblast dives deep into red result territory

30 Aug 2017 - Mesoblast (ASX:MSB) has reported a further dive into negative territory with its attributable lost falling to US$76.8 million in the 2017 financial year.

In the black: Aus shares close 0.36% higher

25 May 2017 - In the black: Aus shares close 0.36% higher. WorleyParsons Limited (ASX:WOR) has been awarded a five year agreement by Refining NZ for engineering, procurement and m…

Mesoblast records US$9.8M 1Q2017 loss

25 May 2017 - Mesoblast Limited (ASX:MSB) has announced a net loss attributable to shareholders of US$9.8 million for the first quarter of 2017.

The trend is your friend

12 Apr 2017 - Investment advisor Gary Glover takes a technical look at S&P/ASX200, Dow Jones Industrials, Flight Centre Travel Group, Doray Minerals, Woodside Petroleum, BHP Billi…

On the rebound: Aus shares 0.56% higher at noon

10 Apr 2017 - On the rebound: Aus shares 0.56% higher at noon. Mesoblast Limited (ASX:MSB) has announced that the Phase 3 trial of its precursor cell product in patients with mode…

Negative territory: Aus shares 0.49% lower at noon

06 Apr 2017 - Negative territory: Aus shares 0.49% lower at noon. Mesoblast Limited (ASX:MSB) has announced that it has received $3.7 million from the Australian government for re…

Flat finish: Aus shares close 0.12% lower

27 Mar 2017 - Flat finish: Aus shares close 0.12% lower. Mesoblast Limited (ASX:MSB) has announced that it has completed a fully underwritten institutional placement of 26.25 mill…

Maintaining gains: Aus shares close 0.26% higher

07 March 2017 - Maintaining gains: Aus shares close 0.26% higher. Creso Pharma Limited (ASX:CPH) has signed a binding Letter of Intent with high-tech Swiss food and pharma company …

Mesoblast gets Fast Track designation from US FDA

07 Mar 2017 - US Food and Drug Administration grants a Fast Track designation to regenerative medicine company, Mesoblast Ltd (ASX:MSB), for the use of its cell therapy (MSC-100-IV…

When will XJO hit 6000?

22 Feb 2017 - Investment advisor Gary Glover takes a technical look at Dow Jones Industrials, S&P/ASX200, Lendlease Group, Brambles, SKYCITY Entertainment Group, Infomedia, Estia H…

Mesoblast inks deal with global pharma company

23 Dec 2016 - Mesoblast Limited (ASX:MSB) announces it has entered into an equity purchase agreement with Mallinckrodt Pharmaceuticals to further develop 2 of its lower back pain t…

Slide continues: Aus shares close 0.37% lower

15 Nov 2016 - Slide continues: Aus shares close 0.37% lower. Ainsworth Game Technology (ASX:AGI) says it expects international revenues to continue to grow in FY17.

Mesoblast 1Q17 gross profit falls 74%

15 Nov 2016 - Mesoblast Ltd (ASX:MSB) reports loss before tax of $22.9 million in 1Q17 – a 74% decline in profit.

Fed fears: Aus shares close 0.32% lower

01 Sep 2016 - Fed fears: Aus shares close 0.32% lower. Mesoblast Limited (ASX:MSB) has announced that the former chief executive of Roche Pharmaceuticals has been appointed as Vic…

Banks lead the way as ASX200 gains 0.15% at noon

09 Aug 2016 - Banks lead the way as ASX200 gains 0.15% at noon. Mesoblast Limited (ASX:MSB) announces Phase 2 trial results of its cell-therapy has shown improvements in patients w…

Markets approaching key resistance

27 Jul 2016 - Investment advisor Gary Glover takes a technical look at S&P/ASX200, Dow Jones, All Ords, CPU, FLT, BGA, CIM, MSB and PAC.

Market Wrap: Aus shares close 0.26% higher

01 Jan 2016 - Aus shares close 0.26% higher. Mesoblast Limited (ASX:MSB) has announced plans for an early data read out on its Phase 3 chronic heart failure trial.

Midday: Aus shares track 0.93% lower at noon

10 Jun 2016 - Aus shares track 0.93% lower at noon. Wellard Limited (ASX:WLD) says the company’s earnings for the year ended 30 June 2016 will be lowered by several factors.

Midday: Aus shares track 0.58% higher at noon

03 Jun 2016 - Aus shares track 0.58% higher at noon. Countplus Limited (ASX:CUP) has executed an unconditional agreement to sell a Brisbane based member firm, Change Accountants a…

Mesoblast receives $6.2M for R&D

20 May 2016 - Mesoblast Limited (ASX:MSB) announces it has received $6.2 million from the Australian Government.

Market Wrap: Aus shares close 0.42% higher

10 May 2016 - Aus shares close 0.42% higher. Lithium Australia (ASX:LIT) says a number of Western Australian graphite assets acquired by the company are to be divested.

Mesoblast revenue hits $4.1M in Q3

10 May 2016 - Mesoblast Limited (ASX:MSB) records a small slip in revenue to US$4.1 million for Q3 2016.

Mesoblast talks therapy on knee osteoarthritis

01 Apr 2016 - Mesoblast Limited (ASX:MSB) says an injection of its MPC product candidate, resulted in an improvement in pain, function and cartilage structure in patients with post…

Midday: Aus shares track 1% lower at noon

24 Mar 2016 - Aus shares track 1% lower at noon. Beach Energy Limited (ASX:BPT) has provided the market with an update on its merger with Drillsearch Energy, saying it will incur …

Mesoblast talks development of cell-based medicines

22 Mar 2016 - Mesoblast Limited (ASX:MSB) CEO Professor Silviu Itescu discusses the company’s latest trial results and near-term value inflexion points at the ASX CEO Sessions in S…